Event-Driven Stocks

LifeStance Health Group, Inc.

LFSTNasdaq

Healthcare · Services-Health Services · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs5 good1 warningdetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$1.42B$1.25B$1.06B$859.5M$1.4M$14,000
Operating income$24.1M−$31.6M−$189.1M−$210.2M−$286.4M$8.7M
Net income$9.7M−$57.4M−$186.3M−$215.6M−$307.2M−$24.9M
Total assets$2.20B$2.12B$2.11B$2.17B$1.93B$1.57B
Total liabilities$682.9M$672.0M$681.0M$655.1M$382.1M$536.9M
Equity$1.52B$1.45B$1.43B$1.52B$1.55B$997.8M
EPS (diluted)
Shares out.384.6M380.7M376.4M374.3M374.3M0

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
1.7%
Net margin
0.7%
Return on equity
0.6%
Return on assets
0.4%
Return on capital (ROCE)
1.2%
Liabilities / assets
31.0%
Debt / equity
0.45×
Book value / share
$3.96
Revenue growth (YoY)
13.9%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
1.70grey zone
Accruals / assets
6.2%clean
Piotroski F-Score
8/9strong

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
82
/ 100
Profitability 100Growth 100Catalyst 33Earnings quality 100Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

1 warning5 good
  • Altman Z″ in the grey zone
  • Operating margin is positive
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20268.6M1.1+24.3%
Apr 30, 20266.9M1.2+5.1%
Apr 15, 20266.6M4.2-8.8%
Mar 31, 20267.2M3.5-7.7%
Mar 13, 20267.8M2.8-24.4%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.